Adainistration of morphine has diverse effects on various endocrine systems believed to reflect the action of this ding on hypothalamic endocrine control mechanisms. For example, morphine administration results in inhibition of ovulation in rats (Cicero et al., 1976; Packman and Rothchild, 1976 ) and reduces the proestrous increase of circulating luteinizing hormone (Pang et al., 1977) . Both of these effects are reversed by treatment with the opiate antagonist naloxone.
Intrahvpothalamic (Lotti et al., 1969) and peripheral (Kokka and George, 1974 ) morphine injections stimulate the secretion of adrenocorticotrophic hormone (ACTH) from the pituitary, as reflected by increased plasma levels of adrenal corticosterone in the rat. This stimulation is also abolished by naloxone pretreatment (Kokka and George, 1974) . Morphine also stimulates the release of growth hormone, but this effect is not alrered by naloxone pretreatment (Kokka and George, 1974) .
It has been demonstrated that ACTH can competitively inhibit opiate binding in vitro showing mixed agonist-antagonist actions (Krivoy et al., 1977; Terenius et al., 1975; Wiegant et al., 1977) . In vivo studies have shown that naloxone blocks the effect of chronic ACTH treatment in retarding the development of reproductive function in mice (Yasukawa et al., 1978) .
These observations suggest that compounds with an affinity for opiate receptors might interact with ACTH receptors. We investigated this hypothesis by determining in viva the action of acute morphine, 6-endorphin, and naloxone pretreatment on the steriodogenic response of the adrenal cortex to ACTH.
Materials and methods
Yale Sprague-Lawley rats weighing 100 110 g (Simonsen Laboratories, Gilroy, Calif.) were used. The rats were hotmed 5 per cage in large plastic cages and maintained with free access to food and water in an animal colony .&with controlled temperature (23%) on a regulated photoperiod of 12L:12D
(lights on at 0800 h).
Drugs used and their suppliers mere: Aj=-' l i _-= .'."'*ter !Abs, Kankakee, NaCl. Doses of morphine and naloxone were calculated as the free base.
All rats used in these experiments were hyrophysectorized. At 18-20 h prior to drug administration, the pituitary glads were removed under ether anesthesia to eliminate the source of endogenous circulating ACTH. Pituitaries were removed by a transaucicular approach in a stereotaxic instrument (Gay, 1967) . Experimental procedures were carried out between 0800-1100 h on the morning following hypophysectomy.
Initially, each drug was administered to different groups of rats to determine any direct effect they might have on adrenal gland steroidogenesis. determined 20 min following pretreatment with various doses of (-)-morphine (0, 5, 10, and 20 mg/kg, i.p.) or (-)-naloxone (0, 12.5, 25, and 50 mg/kg, i.p.) or 5 min following pretreatment with a-endorphin (100 vg, i.v.). Rats were sacrificed 5 min following ACTH injection for measurement of adrenal corticosterone concentrations.
Finally, the steroidogenic response to ACTH (100 pU, i.v.) was determined 20 min following pretreatment with either the (-)-or (+)-stereoisomeric forms of morphine and naloxone (i.p.). Rats were sacrificed 5 min following the ACTH injection and adrenal glands were removed and processed as described above.
Results are expressed as ug of corticosterone per 100 mg of adrenal gland tissue, fresh weight. The data were statistically analyzed by using overall one-way analyses of variance followed by constructing 95% confidence limits around the appropriate control group mean with the conservative post-hoc procedure of Dunnett (Keppel, 1973) .
Results

Effect of ACTH, morphine, and naloxone on adrenal gland content of corticosterone
As shown in Table 1 Similarly, (-)-naloxone (10 mg/kg) inhibited the response to ACTH (p < 0.05) while (+)-naloxone (10 mg/kg) was without effect. When (-)-naloxone (10 mg/kg) was injected prior to the (-)-morphine (10 mg/kg), the response of the adrenal cortex to ACTH (100 pU) did not differ from the steroidogenic response to the injection of ACTH alone. Pretreatment with 6-eudurphin (100 ug) 5 min prior to ACTH injection (100 uU) had no effect on the steroidogenic response of the adrenal.
Discussion
Morphine administration has been shown to stimulate corticosterone secretion and adrenal gland function (Briggs and Munson, 1955) . This response has been presumed to be mediated solely by the hypothalamic-pituitary axis or by a direct action at the pituitary (Kokka and George, 1974; Lotti et al., 1969; Zimmerman and Critchlow, 1973) . The present results indicate that h .0' morphine can also influence the steroidogenic response to ACTH by a direct action on the adrenal cortex.
At doses up to 10 mg/kg, the potentiation of ACTR-induced steroidogenesis by morphine appears to be dose-dependent and stereospecific since (+)-morphine was without effect. The opiate antagonist naloxone exerted effects on the steroidogenic response to AC R that were also stereospecific and dose-dependent but opposite to those of morphine. In addition, naloxone prevented the potentiation by morphine of the ACTH-induced steroidogenic response. These results suggest that morphine and naloxone interact with receptors on corticosterone-secreting cells of the adrenal cortex.
It has been shown that addition of the opiate antagonists naloxone or naltrexone to dispersed rat adrenal cell preparations inhibited the steroidogenic response to ACTH, but had no effect on the steroidogenic response to the addition of dibutyryl cyclic AMP (Ginsburg et al., 1978) . This observation and our results lend further support to the hypothesis that naloxone and, presumably, morphine exert effects on the adrenocortical response to ACTH by competition at ACTH adrenal receptor sites.
Alternately, mediation by an adrenal opiate receptor must also be considered. However, this is unlikely since, in the present work, the administration of 8-endorphin or of morphine alone, at doses up to 20 mg/kg, did not stimulate steroidogenesis. Morphine's effect was only detectable in the presence of ACTH. Furthermore, other work has failed to demonstrate the presence of specific opiate receptor binding in adrenal-gland homogenates (Simantov et al., 1978) .
The evidence that ACTH can interact with opiate receptors in the central nervous system and in the periphery (Krivoy et al., 1977; Gispen et al., 1976; Terenius et al., 1975; Wiegant et al., 1977) suggests the possibility that and enkephalins may bind differently to the same receptor or exert their opiate-like effects by binding to different receptors but with overlapping specificity (Hazum et al., 1979) . 
